ATE222771T1 - Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren - Google Patents

Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren

Info

Publication number
ATE222771T1
ATE222771T1 AT96904605T AT96904605T ATE222771T1 AT E222771 T1 ATE222771 T1 AT E222771T1 AT 96904605 T AT96904605 T AT 96904605T AT 96904605 T AT96904605 T AT 96904605T AT E222771 T1 ATE222771 T1 AT E222771T1
Authority
AT
Austria
Prior art keywords
composition
infections caused
respiratory viruses
preventing infections
virus
Prior art date
Application number
AT96904605T
Other languages
English (en)
Inventor
Milo Duane Hilty
Steven Neal Anderson
Joseph Paul Schaller
Jin-Zhou Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23526176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE222771(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE222771T1 publication Critical patent/ATE222771T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Water Treatments (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Water Treatment By Sorption (AREA)
  • Materials For Medical Uses (AREA)
AT96904605T 1995-02-10 1996-02-08 Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren ATE222771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/386,576 US5922344A (en) 1995-02-10 1995-02-10 Product for prevention of respiratory virus infection and method of use
PCT/US1996/001790 WO1996031186A2 (en) 1995-02-10 1996-02-08 Product and method for preventing respiratory virus infection

Publications (1)

Publication Number Publication Date
ATE222771T1 true ATE222771T1 (de) 2002-09-15

Family

ID=23526176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904605T ATE222771T1 (de) 1995-02-10 1996-02-08 Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren

Country Status (11)

Country Link
US (1) US5922344A (de)
EP (1) EP0808173B1 (de)
JP (1) JP2002517167A (de)
AT (1) ATE222771T1 (de)
AU (1) AU4866696A (de)
CA (1) CA2212562A1 (de)
DE (1) DE69623261T2 (de)
DK (1) DK0808173T3 (de)
ES (1) ES2184853T3 (de)
PT (1) PT808173E (de)
WO (1) WO1996031186A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701026D0 (sv) * 1997-03-20 1997-03-20 Immun System Ims Ab use of avian antibodies
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
WO2007101441A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
KR101423586B1 (ko) * 2006-08-25 2014-07-25 폴 코포레이션 정화 요소를 포함하는 유체 조립체
JP2010534057A (ja) * 2007-03-06 2010-11-04 シムフォゲン・アクティーゼルスカブ 呼吸器合胞体ウイルス感染症を治療するための組換え抗体
WO2009042589A1 (en) * 2007-09-24 2009-04-02 Vanderbilt University Monoclonal antibodies to respiratory syncytial virus and uses thereof
WO2022243979A1 (en) * 2021-05-20 2022-11-24 Lactiga, Inc. Polyclonal antibodies to treat respiratory syncytial virus
US20230397620A1 (en) * 2022-06-08 2023-12-14 Bby, Inc. Powderization of Human Milk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
CA2040770A1 (en) * 1990-04-19 1991-10-20 James F. Young Administration of monoclonal antibodies against respiratory viruses
WO1992001473A1 (en) * 1990-07-19 1992-02-06 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
CA2109528A1 (en) * 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
WO1994017105A1 (en) * 1993-01-29 1994-08-04 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
JPH06345668A (ja) * 1993-06-07 1994-12-20 Shibayagi:Kk 感染防御組成物およびその用途

Also Published As

Publication number Publication date
EP0808173A2 (de) 1997-11-26
JP2002517167A (ja) 2002-06-11
ES2184853T3 (es) 2003-04-16
US5922344A (en) 1999-07-13
EP0808173B1 (de) 2002-08-28
DE69623261T2 (de) 2003-04-17
PT808173E (pt) 2003-01-31
DK0808173T3 (da) 2002-11-04
CA2212562A1 (en) 1996-10-10
WO1996031186A2 (en) 1996-10-10
AU4866696A (en) 1996-10-23
WO1996031186A3 (en) 1996-11-14
DE69623261D1 (de) 2002-10-02
MX9706098A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
TW200501985A (en) Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
BR9711095A (pt) Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
ATE427129T1 (de) Abgabevorrichtung fur arzneimittel
BR0111569A (pt) Agentes antivirais de imidazopiridina e imidazopirimidina
BR0208986A (pt) Solução oral de aripiprazol
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
BR0113755A (pt) Composto multimérico, processo para a preparação de composto, composição farmacêutica que compreende o composto, processo para o tratamento e/ou profilaxia e detecção de uma infecção por virus, utilização do composto, e inalador que contém a composição
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
ATE222771T1 (de) Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
PT915707E (pt) Composicao farmaceutica que compreende um constituinte amiloide p de soro e que se destina ao tratamento profilatico ou terapeutico de infeccoes virais e estojo para a deteccao da fixacao de composicoes aos componentes de virus
BR9905352A (pt) Formas atenuadas do vìrus da diarréia bovina
ATE172198T1 (de) Verfahren zur herstellung von n-acetyl- neuraminsäurederivaten
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
BR9808392A (pt) Uso de anticorpos de aves, e, processo para tratar infecções do trato respiratório.
BRPI0512951A (pt) compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha)
KR970701561A (ko) 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)
DE69230790D1 (de) Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0808173

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked